Muscle News and Research

RSS

Pesticides and nerve agents explain health problems in Persian Gulf war veterans

A study by researchers at the University of California, San Diego School of Medicine shows there is increasing evidence that high rates of illness in Persian Gulf War Veterans can be explained, in part, by exposure to certain chemicals, including pesticides and nerve agents.

11 Mar 2008

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.

11 Mar 2008

Exercise doesn't stop the clock on aging, but it seems to slow it down

Evidence continues to mount that exercise provides many benefits to help people look and feel younger. The March issue of Mayo Clinic Women's HealthSource offers a recap of the many benefits of regular exercise.

6 Mar 2008

Researchers discover molecular pathway in blood vessels that controls blood pressure and vascular function

University of Iowa researchers have identified a molecular pathway in blood vessels that controls blood pressure and vascular function and may help explain why certain drugs for type II diabetes also appear to lower patients' blood pressure.

6 Mar 2008

New potential drug target for atherosclerosis

A nuclear receptor protein, known for controlling the ability of cells to burn fat, also exerts powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice prone to developing the harmful plaques, according to new research by scientists at the Salk Institute for Biological Studies and the Harvard School of Public Health.

6 Mar 2008

Novel imaging technique provides comprehensive diagnosis of heart disease

In the current issue of the journal Circulation, a research team from the Medical University of South Carolina's (MUSC) Heart & Vascular Center report their initial experience with a novel imaging technique that enables comprehensive diagnosis of heart disease based on a single computerized tomographic (CT) scan.

6 Mar 2008

Bioniche receives fast track for bladder cancer therapy

Bioniche Life Sciences Inc. has announced that it has received notice from the U.S. Food and Drug Administration (FDA) that its therapy for first-line non-muscle-invasive bladder cancer meets the criteria for Fast Track designation.

6 Mar 2008

Cell proteins could offer a future drug target against weight gain

Two cell proteins that relax the gut and help accommodate a big meal have been identified by UCL (University College London) scientists.

4 Mar 2008

How variants of a specific gene, CAPON or NOS1AP, can disrupt normal heart rhythm

A research team from the Cedars-Sinai Heart Institute, Johns Hopkins University and China Medical University and Hospital in Taiwan have described for the first time the mechanisms by which variants of a specific gene, CAPON or NOS1AP, can disrupt normal heart rhythm.

4 Mar 2008

Tiny RNA molecule found to help create skin's protective barrier

Every minute, 30,000 of our outermost skin cells die so that we can live. When they do, new cells migrate from the inner layer of the skin to the surface of it, where they form a tough protective barrier.

4 Mar 2008

Ten years down the line a pill to cure obesity

British scientists say they may have found a new way to treat obesity by stopping the stomach from expanding.

4 Mar 2008

Short RNA strand helps exposed skin cells protect body from bacteria, dehydration and even cancer

Every minute, 30,000 of our outermost skin cells die so that we can live.

3 Mar 2008

National Institute for Health and Clinical Excellence (NICE) releases appraisal consultation document on treatment of pulmonary arterial hypertension in adults

The National Institute for Clinical Excellence (NICE) has published on its website the preliminary recommendations of its Appraisal Committee on the use of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for the treatment of pulmonary hypertension in adults.

3 Mar 2008

Snoring linked to cardiovascular disease, increased health-care utilization

Loud snoring with breathing pauses is associated with an increased risk of cardiovascular disease and increased health care utilization, according to a study published in the March 1 issue of the journal SLEEP.

3 Mar 2008

Children with obstructive sleep apnea have abnormal respiratory-related evoked potentials

Children with obstructive sleep apnea (OSA) have abnormal respiratory-related evoked potentials compared to other children their age.

3 Mar 2008

New online information resource on bladder problems

Women with bladder control problems can learn about treatments and techniques to help them manage their condition in a new resource from the National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC), an information dissemination service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH).

1 Mar 2008

Real-time imaging device may improve surgery for congenital colon disease

Researchers at Cedars-Sinai Medical Center are developing a spectral imaging system that could result in shorter operating times for infants undergoing surgery for Hirschsprung's disease, according to a mouse study reported in the Journal of Biophotonics.

1 Mar 2008

Diabetes is rapidly increasing globally, and Asian Indians have the highest prevalence

The incidence of type 2 diabetes is rising, especially in urbanized parts of the world where sedentary lifestyles and obesity abound.

1 Mar 2008

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.

1 Mar 2008

Lilly knocked back by FDA on Zyprexa for schizophrenia treatment

Eli Lilly and Company has received a not approvable letter from the U.S. Food and Drug Administration for Zyprexa long-acting injection (olanzapine LAI) for the treatment and maintenance treatment of schizophrenia in adults, the company announced.

28 Feb 2008

Muscle News and Research

Pesticides and nerve agents explain health problems in Persian Gulf war veterans

Femara helps protect against return of breast cancer after completing Tamoxifen therapy

Exercise doesn't stop the clock on aging, but it seems to slow it down

Researchers discover molecular pathway in blood vessels that controls blood pressure and vascular function

New potential drug target for atherosclerosis

Novel imaging technique provides comprehensive diagnosis of heart disease

Bioniche receives fast track for bladder cancer therapy

Cell proteins could offer a future drug target against weight gain

How variants of a specific gene, CAPON or NOS1AP, can disrupt normal heart rhythm

Tiny RNA molecule found to help create skin's protective barrier

Ten years down the line a pill to cure obesity

Short RNA strand helps exposed skin cells protect body from bacteria, dehydration and even cancer

National Institute for Health and Clinical Excellence (NICE) releases appraisal consultation document on treatment of pulmonary arterial hypertension in adults

Snoring linked to cardiovascular disease, increased health-care utilization

Children with obstructive sleep apnea have abnormal respiratory-related evoked potentials

New online information resource on bladder problems

Real-time imaging device may improve surgery for congenital colon disease

Diabetes is rapidly increasing globally, and Asian Indians have the highest prevalence

AstraZeneca submits sNDA for SEROQUEL XR for treatment of major depressive disorder

Lilly knocked back by FDA on Zyprexa for schizophrenia treatment

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News